Search Results

The Optilite IgG3 Kit is intended for the quantitative in vitro measurement of IgG3 in serum using the Binding Site Optilite analyser. Measurement of this immunoglobulin is an aid in the diagnosis of abnormal protein metabolism and the body's lack of ability to resist infectious agents. The test result should be used in conjunction with other laboratory and clinical findings.

Not Found

I'm sorry, but the provided text does not contain the detailed information necessary to describe the acceptance criteria and the study that proves the device meets them in the format requested. The document is a 510(k) clearance letter from the FDA for a device called "Optilite® IgG3 Kit," outlining its approval and general regulatory compliance. It does not include performance data, study design, sample sizes, expert qualifications, or ground truth establishment.

Specifically, the document contains:

• Device Name: Optilite® IgG3 Kit
• Intended Use: Quantitative in vitro measurement of IgG3 in serum using the Binding Site Optilite analyser. Aid in the diagnosis of abnormal protein metabolism and resistance to infectious agents.
• Regulatory Information: 510(k) number, regulation number, product code, regulatory class.
• FDA Clearance Statement: Confirmation of substantial equivalence to a predicate device.
• General Controls Information: Reminders about registration, listing, GMP, labeling, etc.

It does not include:

• A table of acceptance criteria and reported device performance.
• Sample sizes for test or training sets.
• Data provenance.
• Number of experts or their qualifications for ground truth.
• Adjudication methods.
• Information on MRMC comparative effectiveness studies.
• Information on standalone algorithm performance.
• Details on the type of ground truth used or how it was established.

Therefore, I cannot fulfill your request based on the provided text.

Ask a specific question about this device